What is Masimo Corp's earnings per share (EPS)?

Masimo Corp (MASI) reported diluted earnings per share of $-2.80 for fiscal year 2026. This represents a 50.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Masimo Corp Financials

MASI

Source SEC Filings (10-K/10-Q) Updated Jan 3, 2026 Currency USD FYE January

This page shows Masimo Corp (MASI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Mixed

-1.44x

For every $1 of reported earnings, Masimo Corp generates $-1.44 in operating cash flow ($217.8M OCF vs -$151.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

9.3x

Masimo Corp earns $9.3 in operating income for every $1 of interest expense ($310.0M vs $33.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.5B

YoY+9.4%

5Y CAGR+10.2%

10Y CAGR+10.8%

Masimo Corp generated $1.5B in revenue in fiscal year 2026. This represents an increase of 9.4% from the prior year.

EBITDA

$348.8M

YoY+212.8%

5Y CAGR+7.3%

10Y CAGR+14.4%

Masimo Corp's EBITDA was $348.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 212.8% from the prior year.

Net Income

-$151.5M

YoY+50.3%

Masimo Corp reported -$151.5M in net income in fiscal year 2026. This represents an increase of 50.3% from the prior year.

EPS (Diluted)

$-2.80

YoY+50.0%

Masimo Corp earned $-2.80 per diluted share (EPS) in fiscal year 2026. This represents an increase of 50.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$198.4M

YoY+13.2%

5Y CAGR+5.3%

10Y CAGR+15.8%

Masimo Corp generated $198.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 13.2% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

61.9%

YoY+5.0pp

5Y CAGR-5.2pp

10Y CAGR-3.7pp

Masimo Corp's gross margin was 61.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 5.0 percentage points from the prior year.

Operating Margin

20.3%

YoY+15.8pp

5Y CAGR-3.3pp

10Y CAGR+5.7pp

Masimo Corp's operating margin was 20.3% in fiscal year 2026, reflecting core business profitability. This is up 15.8 percentage points from the prior year.

Net Margin

-9.9%

YoY+11.9pp

5Y CAGR-30.8pp

10Y CAGR-20.6pp

Masimo Corp's net profit margin was -9.9% in fiscal year 2026, showing the share of revenue converted to profit. This is up 11.9 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$126.4M

YoY-30.6%

5Y CAGR+6.3%

10Y CAGR+8.6%

Masimo Corp invested $126.4M in research and development in fiscal year 2026. This represents a decrease of 30.6% from the prior year.

Share Buybacks

$363.7M

5Y CAGR+57.5%

10Y CAGR+33.8%

Masimo Corp spent $363.7M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$19.4M

YoY-8.1%

5Y CAGR-22.3%

10Y CAGR+7.5%

Masimo Corp invested $19.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 8.1% from the prior year.

MASI Income Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Revenue	$1.5B+9.4%	$1.4B+9.4%	$1.3B-37.3%	$2.0B+78.0%	$1.1B+22.0%	$937.8M
Cost of Revenue	$581.7M-3.2%	$600.9M+17.8%	$509.9M-47.8%	$977.0M+143.8%	$400.7M+29.8%	$308.7M
Gross Profit	$945.2M+19.0%	$794.3M+3.7%	$765.6M-27.7%	$1.1B+42.5%	$743.0M+18.1%	$629.2M
R&D Expenses	$126.4M-30.6%	$182.2M+39.6%	$130.5M-31.8%	$191.4M+61.2%	$118.7M+27.2%	$93.3M
SG&A Expenses	$506.0M-7.8%	$548.6M+21.6%	$451.3M-31.4%	$657.4M+78.2%	$369.0M+17.3%	$314.7M
Operating Income	$310.0M+392.1%	$63.0M-62.0%	$166.0M-21.0%	$210.0M-17.9%	$255.8M+15.6%	$221.2M
Interest Expense	$33.2M-19.4%	$41.2M-18.1%	$50.3M+95.7%	$25.7M+8466.7%	$300K-8.5%	$328K
Income Tax	$64.9M+1058.9%	$5.6M+5.7%	$5.3M-89.4%	$49.9M+113.2%	$23.4M-38.3%	$38.0M
Net Income	-$151.5M+50.3%	-$304.9M-474.1%	$81.5M-43.2%	$143.5M-40.3%	$240.3M+22.5%	$196.2M
EPS (Diluted)	$-2.80+50.0%	$-5.60-470.9%	$1.51-41.9%	$2.60-37.2%	$4.14+20.3%	$3.44

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$412.5M+11.0%	$371.5M+0.2%	$370.9M-0.3%	$372.0M+1.0%	$368.4M+7.3%	$343.3M-0.2%	$343.9M+1.3%	$339.6M
Cost of Revenue	$165.2M+17.2%	$140.9M+2.4%	$137.6M-0.3%	$138.0M-31.0%	$200.1M+52.5%	$131.2M-4.0%	$136.6M+2.7%	$133.0M
Gross Profit	$247.3M+7.2%	$230.6M-1.2%	$233.3M-0.3%	$234.0M+39.0%	$168.3M-20.7%	$212.1M+2.3%	$207.3M+0.3%	$206.6M
R&D Expenses	$32.1M+5.2%	$30.5M+2.0%	$29.9M-11.8%	$33.9M-50.1%	$68.0M+82.3%	$37.3M-4.6%	$39.1M+3.4%	$37.8M
SG&A Expenses	$131.3M+12.8%	$116.4M-16.2%	$138.9M+16.3%	$119.4M-29.8%	$170.0M+24.5%	$136.6M+8.2%	$126.3M+9.2%	$115.7M
Operating Income	$83.9M+0.4%	$83.6M+29.6%	$64.5M-17.3%	$78.0M+211.1%	-$70.2M-283.8%	$38.2M-8.8%	$41.9M-21.1%	$53.1M
Interest Expense	$7.4M-15.9%	$8.8M+7.3%	$8.2M-6.8%	$8.8M+1.1%	$8.7M-12.1%	$9.9M-6.6%	$10.6M-11.7%	$12.0M
Income Tax	$12.0M-43.4%	$21.2M+101.9%	$10.5M-50.5%	$21.2M+244.2%	-$14.7M-400.0%	$4.9M-18.3%	$6.0M-36.2%	$9.4M
Net Income	$68.3M+168.0%	-$100.4M-295.7%	$51.3M+130.1%	-$170.7M+51.2%	-$349.6M-3667.3%	$9.8M-38.8%	$16.0M-15.3%	$18.9M
EPS (Diluted)	N/A	$-1.84-295.7%	$0.94+130.1%	$-3.12	N/A	$0.18-40.0%	$0.30-14.3%	$0.35

MASI Balance Sheet

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Total Assets	N/A	$2.6B-13.7%	$3.0B-5.3%	$3.2B+100.9%	$1.6B+14.4%	$1.4B
Current Assets	N/A	$1.2B-0.5%	$1.2B-5.9%	$1.3B+33.1%	$983.1M-1.3%	$996.1M
Cash & Equivalents	N/A	$123.6M-24.2%	$163.0M-19.7%	$202.9M-63.2%	$552.0M-2.8%	$567.7M
Inventory	N/A	$294.8M-45.9%	$545.0M+8.8%	$501.0M+131.8%	$216.1M+86.5%	$115.9M
Accounts Receivable	N/A	$283.2M+26.3%	$224.2M-49.7%	$445.9M+232.0%	$134.3M+1.4%	$132.4M
Goodwill	N/A	$96.7M-1.9%	$98.6M-77.9%	$445.4M+336.3%	$102.1M+356.8%	$22.4M
Total Liabilities	N/A	$1.6B-6.1%	$1.7B-10.4%	$1.9B+594.0%	$269.7M+18.2%	$228.3M
Current Liabilities	N/A	$617.7M+9.6%	$563.8M-10.5%	$630.0M+220.0%	$196.9M+14.3%	$172.2M
Long-Term Debt	N/A	$714.3M-18.1%	$871.7M-7.4%	$941.6M	N/A	N/A
Total Equity	N/A	$1.1B-22.9%	$1.4B+1.9%	$1.3B+0.8%	$1.3B+13.7%	$1.2B
Retained Earnings	N/A	$1.5B-17.0%	$1.8B+4.8%	$1.7B+22.9%	$1.4B+26.7%	$1.1B

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$1.7B-6.5%	$1.8B-24.4%	$2.4B+4.8%	$2.3B-12.7%	$2.6B-15.0%	$3.1B+6.7%	$2.9B-2.2%	$3.0B
Current Assets	$926.0M-11.7%	$1.0B-17.4%	$1.3B+7.2%	$1.2B-3.4%	$1.2B-4.2%	$1.3B+12.1%	$1.1B-2.0%	$1.2B
Cash & Equivalents	$152.3M-51.2%	$312.3M+108.8%	$149.6M+14.4%	$130.8M+5.8%	$123.6M-22.0%	$158.5M+22.3%	$129.6M-17.8%	$157.6M
Inventory	$380.3M+12.3%	$338.6M+6.3%	$318.5M+5.7%	$301.2M+2.2%	$294.8M-48.3%	$569.9M+11.1%	$513.0M+1.4%	$506.1M
Accounts Receivable	$275.8M	N/A	N/A	N/A	$283.2M-23.7%	$371.0M+9.9%	$337.7M+2.1%	$330.7M
Goodwill	$101.0M+0.2%	$100.8M-0.1%	$100.9M+2.6%	$98.3M+1.7%	$96.7M-76.6%	$412.5M+6.0%	$389.0M-1.8%	$396.0M
Total Liabilities	$977.7M-3.0%	$1.0B-25.9%	$1.4B+1.0%	$1.3B-14.4%	$1.6B-3.1%	$1.6B+6.5%	$1.5B-4.2%	$1.6B
Current Liabilities	$371.6M+0.5%	$369.7M-37.6%	$592.1M+8.3%	$546.5M-11.5%	$617.7M-3.1%	$637.6M+16.7%	$546.2M+8.3%	$504.2M
Long-Term Debt	$518.0M-7.4%	$559.1M-6.6%	$598.7M-5.9%	$636.0M-11.0%	$714.3M-2.6%	$733.2M-1.8%	$746.5M-11.3%	$841.4M
Total Equity	$721.2M-11.0%	$810.0M-22.3%	$1.0B+10.2%	$946.4M-10.0%	$1.1B-28.1%	$1.5B+6.9%	$1.4B+0.3%	$1.4B
Retained Earnings	$1.3B+5.4%	$1.3B-7.3%	$1.4B+3.9%	$1.3B-11.4%	$1.5B-19.0%	$1.8B+0.5%	$1.8B+0.9%	$1.8B

MASI Cash Flow Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	$217.8M+10.9%	$196.4M+108.7%	$94.1M+220.1%	$29.4M-86.1%	$211.1M-4.8%	$221.6M
Capital Expenditures	$19.4M-8.1%	$21.1M-45.1%	$38.4M-27.3%	$52.8M-27.2%	$72.5M+6.0%	$68.4M
Free Cash Flow	$198.4M+13.2%	$175.3M+214.7%	$55.7M+338.0%	-$23.4M-116.9%	$138.6M-9.6%	$153.3M
Investing Cash Flow	$275.1M+637.3%	-$51.2M+36.9%	-$81.2M+92.3%	-$1.1B-1177.4%	-$82.8M+58.1%	-$197.7M
Financing Cash Flow	-$520.7M-314.6%	-$125.6M-120.0%	-$57.1M-111.0%	$520.4M+1058.4%	-$54.3M-481.4%	-$9.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$363.7M	$0	$0-100.0%	$401.5M+263.3%	$110.5M+194.2%	$37.6M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$60.5M+6.5%	$56.8M-18.2%	$69.4M+123.2%	$31.1M-38.4%	$50.5M+97.3%	$25.6M-65.6%	$74.5M+62.7%	$45.8M
Capital Expenditures	$7.1M+20.3%	$5.9M+55.3%	$3.8M+46.2%	$2.6M-58.1%	$6.2M+19.2%	$5.2M+44.4%	$3.6M-41.0%	$6.1M
Free Cash Flow	$53.4M+4.9%	$50.9M-22.4%	$65.6M+130.2%	$28.5M-35.7%	$44.3M+117.2%	$20.4M-71.2%	$70.9M+78.6%	$39.7M
Investing Cash Flow	-$8.7M-103.1%	$282.3M+3168.5%	-$9.2M-186.0%	$10.7M+164.8%	-$16.5M-22.2%	-$13.5M-487.0%	-$2.3M+87.8%	-$18.9M
Financing Cash Flow	-$214.6M+1.7%	-$218.4M-447.4%	-$39.9M+16.5%	-$47.8M-635.4%	-$6.5M-306.3%	-$1.6M+98.2%	-$91.0M-243.4%	-$26.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$186.7M+14.3%	$163.3M	N/A	N/A	$0	$0	N/A	N/A

MASI Financial Ratios

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Gross Margin	61.9%+5.0pp	56.9%-3.1pp	60.0%+8.0pp	52.0%-12.9pp	65.0%-2.1pp	67.1%
Operating Margin	20.3%+15.8pp	4.5%-8.5pp	13.0%+2.7pp	10.3%-12.1pp	22.4%-1.2pp	23.6%
Net Margin	-9.9%+11.9pp	-21.9%-28.2pp	6.4%-0.7pp	7.0%-14.0pp	21.0%+0.1pp	20.9%
Return on Equity	N/A	-29.0%-35.0pp	6.0%-4.8pp	10.7%-7.4pp	18.1%+1.3pp	16.8%
Return on Assets	N/A	-11.6%-14.3pp	2.7%-1.8pp	4.5%-10.6pp	15.0%+1.0pp	14.1%
Current Ratio	N/A	1.98-0.2	2.19+0.1	2.08-2.9	4.99-0.8	5.78
Debt-to-Equity	N/A	0.68+0.0	0.64-0.1	0.70+0.5	0.200.0	0.20
FCF Margin	13.0%+0.4pp	12.6%+8.2pp	4.4%+5.5pp	-1.1%-13.3pp	12.1%-4.2pp	16.3%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	60.0%-2.1pp	62.1%-0.8pp	62.9%0.0pp	62.9%+17.2pp	45.7%-16.1pp	61.8%+1.5pp	60.3%-0.6pp	60.8%
Operating Margin	20.3%-2.2pp	22.5%+5.1pp	17.4%-3.6pp	21.0%+40.0pp	-19.1%-30.2pp	11.1%-1.1pp	12.2%-3.5pp	15.6%
Net Margin	16.6%+43.6pp	-27.0%-40.9pp	13.8%+59.7pp	-45.9%+49.0pp	-94.9%-97.7pp	2.9%-1.8pp	4.7%-0.9pp	5.6%
Return on Equity	9.5%+21.9pp	-12.4%-17.3pp	4.9%+23.0pp	-18.0%+15.2pp	-33.2%-33.9pp	0.7%-0.5pp	1.2%-0.2pp	1.4%
Return on Assets	4.0%+9.5pp	-5.5%-7.7pp	2.1%+9.6pp	-7.4%+5.9pp	-13.3%-13.6pp	0.3%-0.2pp	0.5%-0.1pp	0.6%
Current Ratio	2.49-0.3	2.84+0.7	2.14-0.0	2.17+0.2	1.98-0.0	2.01-0.1	2.09-0.2	2.31
Debt-to-Equity	0.72+0.0	0.69+0.1	0.57-0.1	0.670.0	0.68+0.2	0.50-0.0	0.55-0.1	0.62
FCF Margin	13.0%-0.8pp	13.7%-4.0pp	17.7%+10.0pp	7.7%-4.4pp	12.0%+6.1pp	5.9%-14.7pp	20.6%+8.9pp	11.7%

Similar Companies

Globus Med Inc GMED

$11.7B

Bio Rad Labs Inc BIO

$7.5B

iRhythm Holdings, Inc IRTC

$3.8B

Glaukos Corp GKOS

$6.3B

Bruker Corp BRKR

$5.5B

Frequently Asked Questions

What is Masimo Corp's annual revenue?

Masimo Corp (MASI) reported $1.5B in total revenue for fiscal year 2026. This represents a 9.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Masimo Corp's revenue growing?

Masimo Corp (MASI) revenue grew by 9.4% year-over-year, from $1.4B to $1.5B in fiscal year 2026.

Is Masimo Corp profitable?

No, Masimo Corp (MASI) reported a net income of -$151.5M in fiscal year 2026, with a net profit margin of -9.9%.

What is Masimo Corp's EBITDA?

Masimo Corp (MASI) had EBITDA of $348.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Masimo Corp's gross margin?

Masimo Corp (MASI) had a gross margin of 61.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Masimo Corp's operating margin?

Masimo Corp (MASI) had an operating margin of 20.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Masimo Corp's net profit margin?

Masimo Corp (MASI) had a net profit margin of -9.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Masimo Corp's free cash flow?

Masimo Corp (MASI) generated $198.4M in free cash flow during fiscal year 2026. This represents a 13.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Masimo Corp's operating cash flow?

Masimo Corp (MASI) generated $217.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Masimo Corp's capital expenditures?

Masimo Corp (MASI) invested $19.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Masimo Corp spend on research and development?

Masimo Corp (MASI) invested $126.4M in research and development during fiscal year 2026.

Does Masimo Corp buy back shares?

Yes, Masimo Corp (MASI) spent $363.7M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Are Masimo Corp's earnings high quality?

Masimo Corp (MASI) has an earnings quality ratio of -1.44x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Masimo Corp cover its interest payments?

Masimo Corp (MASI) has an interest coverage ratio of 9.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.